ReviewMethods in molecular biology (Clifton, N.J.)2025
Recent Developments in the Application of Artificial Intelligence and Machine Learning in Early Screening and Diagnosis of Autism.
Review in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autism Spectrum Disorder (ASD or Autism) is a neurodevelopmental disorder that is characterized by challenges in social communication skills and the presence of restricted and repetitive behaviors during early childhood. ASD poses a significant public health challenge with increasing prevalence rates worldwide. Early diagnosis and intervention are critical for improving outcomes in children with ASD. However, current diagnostic methods often involve subjective assessments and are time-consuming. Currently, there are no known biomarkers for ASD, and the diagnosis is based on phenotypic manifestations observed by trained clinicians over time. Additionally, the heterogeneity of Autism and associated co-occurring conditions pose further challenges for screening and early detection. Recent advances in Artificial Intelligence (AI) and Machine Learning (ML) are transforming ASD screening and diagnosis. These computational technologies are capable of analyzing complex datasets and multiple modalities, including multi-omics, brain images, behavior assessments, medical and background information, and registry data to identify patterns that may not be evident to clinicians or parents. This article reviews recent developments in the application of AI/ML for ASD screening and early diagnosis. It also covers the use of AI/ML in understanding the biological underpinnings of ASD.
Indexed as
Identifiers
40553336What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.